12/1
07:48 am
abeo
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Medium
Report
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
12/1
07:30 am
abeo
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/12
02:58 pm
abeo
Abeona Therapeutics Q3 2025: Strong Financials And Zevaskyn Launch Ahead [Seeking Alpha]
Low
Report
Abeona Therapeutics Q3 2025: Strong Financials And Zevaskyn Launch Ahead [Seeking Alpha]
11/12
08:21 am
abeo
Abeona Therapeutics® Reports Third Quarter 2025 Financial Results and Corporate Updates [Yahoo! Finance]
Low
Report
Abeona Therapeutics® Reports Third Quarter 2025 Financial Results and Corporate Updates [Yahoo! Finance]
11/12
07:54 am
abeo
Abeona Therapeutics GAAP EPS of -$0.10 beats by $0.18 [Seeking Alpha]
High
Report
Abeona Therapeutics GAAP EPS of -$0.10 beats by $0.18 [Seeking Alpha]
11/12
07:30 am
abeo
Abeona Therapeutics® Reports Third Quarter 2025 Financial Results and Corporate Updates
High
Report
Abeona Therapeutics® Reports Third Quarter 2025 Financial Results and Corporate Updates
11/10
09:54 am
abeo
Abeona Therapeutics: ZEVASKYN Data Key In Gauging Momentum - Why I Hold [Seeking Alpha]
Low
Report
Abeona Therapeutics: ZEVASKYN Data Key In Gauging Momentum - Why I Hold [Seeking Alpha]
11/7
07:57 am
abeo
Abeona Therapeutics® Announces Date of Third Quarter Financial Results and Upcoming Investor Conference Participation [Yahoo! Finance]
Low
Report
Abeona Therapeutics® Announces Date of Third Quarter Financial Results and Upcoming Investor Conference Participation [Yahoo! Finance]
11/7
07:30 am
abeo
Abeona Therapeutics® Announces Date of Third Quarter Financial Results and Upcoming Investor Conference Participation
Neutral
Report
Abeona Therapeutics® Announces Date of Third Quarter Financial Results and Upcoming Investor Conference Participation
11/3
07:30 am
abeo
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/30
10:45 am
abeo
Abeona Therapeutics® Announces Permanent J-Code for ZEVASKYN® (prademagene zamikeracel)
Low
Report
Abeona Therapeutics® Announces Permanent J-Code for ZEVASKYN® (prademagene zamikeracel)
10/20
08:30 am
abeo
Abeona Therapeutics® Appoints James A. Gow, MD, MBA, MS, MHCM, as Senior Vice President, Head of Clinical Development & Medical Affairs
Low
Report
Abeona Therapeutics® Appoints James A. Gow, MD, MBA, MS, MHCM, as Senior Vice President, Head of Clinical Development & Medical Affairs
10/13
08:07 am
abeo
Abeona Therapeutics (NASDAQ:ABEO) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Low
Report
Abeona Therapeutics (NASDAQ:ABEO) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
10/13
07:39 am
abeo
Abeona Therapeutics® Announces ABO-503 Gene Therapy for X-linked Retinoschisis (XLRS) Selected by FDA for Rare Disease Endpoint Advancement (RDEA) Pilot Program [Yahoo! Finance]
Low
Report
Abeona Therapeutics® Announces ABO-503 Gene Therapy for X-linked Retinoschisis (XLRS) Selected by FDA for Rare Disease Endpoint Advancement (RDEA) Pilot Program [Yahoo! Finance]
10/13
07:30 am
abeo
Abeona Therapeutics® Announces ABO-503 Gene Therapy for X-linked Retinoschisis (XLRS) Selected by FDA for Rare Disease Endpoint Advancement (RDEA) Pilot Program
Medium
Report
Abeona Therapeutics® Announces ABO-503 Gene Therapy for X-linked Retinoschisis (XLRS) Selected by FDA for Rare Disease Endpoint Advancement (RDEA) Pilot Program
10/8
07:51 am
abeo
Abeona Therapeutics® and Children's Hospital Colorado Announce Newest Treatment Center for ZEVASKYN® Gene Therapy [Yahoo! Finance]
Medium
Report
Abeona Therapeutics® and Children's Hospital Colorado Announce Newest Treatment Center for ZEVASKYN® Gene Therapy [Yahoo! Finance]
10/8
07:30 am
abeo
Abeona Therapeutics® and Children's Hospital Colorado Announce Newest Treatment Center for ZEVASKYN® Gene Therapy
Medium
Report
Abeona Therapeutics® and Children's Hospital Colorado Announce Newest Treatment Center for ZEVASKYN® Gene Therapy
10/3
02:37 pm
abeo
Abeona Therapeutics (NASDAQ:ABEO) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Abeona Therapeutics (NASDAQ:ABEO) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
10/1
07:47 am
abeo
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Low
Report
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
10/1
07:30 am
abeo
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
9/9
10:53 am
abeo
Exosome Cell and Gene Therapy Market 2026 Drives by Rising Demand for Personalized Medicine, says Healthcare Experts [Yahoo! Finance]
Low
Report
Exosome Cell and Gene Therapy Market 2026 Drives by Rising Demand for Personalized Medicine, says Healthcare Experts [Yahoo! Finance]